Enterprise Innovation | Weill Cornell Medicine

Based in New York City, Weill Cornell Medicine Enterprise Innovation engages and collaborates with Weill Cornell Medicine faculty and trainees while fostering alliances with leaders in the biomedical industry and business and investment community. Our focus is to translate the application of emerging science and new technologies into world-class medical breakthroughs.

Integrating Weill Cornell Medicine’s different teams and resources under a single, united organization, Enterprise Innovation encompasses the entire spectrum of an effective innovation ecosystem. We offer unique opportunities for faculty and trainees to transform their research into medical advances through collaborations including access to the Tri-Institutional Therapeutics Discovery Institute.

Enterprise Innovation Metrics from FY17 to FY22

515

New Tech Disclosures

189

Issued US Patents

118

Licenses and Options

NewCo Launches

For Inventors and Innovators

Learn about how to collaborate with our team of top-tier business development professionals to bring your innovations to life.

Two men in dark blue suits shaking hands and two women at the table smiling

For Industry, Investors and Partners

Learn about groundbreaking innovations you can partner to fuel a pipeline or launch a new venture.

A Caucasian and an Indian woman holding some booklets and talking

Innovation Ecosystem

Learn more about the infrastructure and different components of Enterprise Innovation.

Four medical students in white coats sitting at a table and listening to a lecture

Programs, Offerings and Support

Explore entrepreneurial programming and education offered by Enterprise Innovation and our ecosystem partners.

Technology Portfolio

Enterprise Innovation brings together the power of industry-leading translational research and clinical care combined with top-tier business development expertise to accelerate innovation to market. Our leading technology portfolio encompasses major pillars of biomedical innovation.

Two doctors and two business reps talking

Collaboration Opportunities

Check out our available research opportunities for potential collaborations.

Events

Sep 25,2023

11:00am to 12:00pm

Bayer's Expert Mondays Webinar: Venture Capital and Investment

A woman with long black hair and light brown skin is wearing a white shirt and dark blue skirt. She is touching an equipment in a lab. The banner also includes the NSF I-Corps Regional Course description, application information and QR code.

Sep 27,2023

9:00am to 5:00pm

I-Corps Regional Courses Application Deadline 9/27/23

Sep 27,2023

12:00pm to 1:00pm

Center for Technology Licensing IP Series #1: Understanding the

Event banner with the title, date and time, sponsors and a black-and-white image of a hand typing on a laptop

Oct 02,2023

10:30am to 11:30am

SBIR/STTR Workshop: Application Process & Funding Options for

Testimonials

John P. Leonard, M.D., Senior Associate Dean of Innovation and Initiatives

Getting new innovations across the finish line requires collaboration, often with industry partners, to scale up findings for application in healthcare. Ultimately, we want the work we do here to have a real impact on patients. By fostering an entrepreneurial environment, we can do that.

Lisa Placanica, Ph.D., Senior Managing Director of the Center for Technology Licensing

There’s obviously fantastic research being done at Weill Cornell Medicine. So we want to work with faculty to identify aspects of their research that could be shaped into a product or a service, work with them to develop it and then to forge the partnership with a commercial entity. We also have to have a finger on the pulse of what industry is looking for: what venture firms are investing in, what pharma is trying to fill their pipeline with. And then we make connections between the two. We have to speak the language between the commercial enterprise and the academic researcher.

Neel Madhukar, Ph.D., Former Postdoc of the Elemento Lab and current CEO of OneThree Biotech

Taking a new technology from an idea to a company is a daunting process for first-time entrepreneurs – and especially in areas like commercialization which isn't a focus of most doctoral work. One thing that helps this is a community of scientists and entrepreneurs who have been through this before and help guide the way. In this way, resources such as the eLab’s Entrepreneurs-in-Residence are invaluable assets.

Francis Barany, Ph.D., Professor of Microbiology and Immunology and National Academy of Inventors Fellow

The professionals at Enterprise Innovation possess strong first-hand knowledge of what it takes to start a company. Their expertise is vital to aspiring faculty scientist/entrepreneurs to launch new companies. Their guidance and feedback has been invaluable throughout the process – they are now helping me with my third company launch.

News

image of man and woman holding hands in the sunlight

NIH Center Grant Bolsters Male Contraceptive Research

September 21, 2023

Weill Cornell Medicine has received a three-year, nearly $6 million grant to lead one of three national contraceptive research centers. The grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, part of the National Institutes of Health, will fund the Weill Cornell Medicine Contraception Development Research Center. Led by Drs.

A male scholar with glasses and grey hair. He's wearing a black shirt and dark blue suit posing in a biology lab.

Budding Entrepreneurial Success at Weill Cornell Medicine-Qatar

September 18, 2023

Dr. Hani Najafi, an assistant professor of cell and developmental biology, was the first WCM-Q participant in the $100K Biomedical Business Plan Challenge Pitch Day competition hosted by the BioVenture eLab. Enterprise Innovation asked him to share his latest study that can lead to potential therapies for cardiometabolic diseases and obesity.

Translating Research into Next Generation Care Through Collaboration